Public - Private Partnership Program
Welcome to the FDA’s Web site on Public-Private Partnerships (PPP).
The FDA’s mission to protect and promote public health requires the Agency to maintain the trust and the confidence of the American public. To do so, the FDA must be seen as a collaborative partner with our stakeholders as we rise to the challenges of bridging scientific gaps.
The development path for all products under the FDA’s regulatory purview is costly and time intensive. Non-traditional business models that leverage expertise and resources from many partners must be developed to tackle scientific problems and to help the FDA make sound regulatory decisions. The high demands for safer, more effective and less costly regulated products create an imperative for strategic partnerships with our stakeholders.
The FDA will need to strengthen and expand the scope of existing partnerships, develop novel business models, and become more proactive if we are to meet our responsibilities as the gold standard for regulatory authority under the Department of Health and Human Services. The FDA must pioneer new paths as we contribute to the development innovative technologies and face new challenges.
The mission of the FDA Public-Private Partnership Program is to create, implement, and manage strategic scientific partnerships under the FDA’s public health mission. Our experienced staff serve as a central resource to FDA Centers and Offices and a variety of partners as we join together to develop creative innovative business models and develop mechanisms for strategic collaborations.
We leverage intellectual capital, infrastructure, and in-kind and financial resources to facilitate successful implementation of programs. Ultimately, the outcomes and know-how from the joint ventures help the FDA make sound regulatory decisions that better serve our stakeholders and the American public.